Related Experiment Video
Updated: May 18, 2026

Multiplex Therapeutic Drug Monitoring by Isotope-dilution HPLC-MS/MS of Antibiotics in Critical Illnesses
Published on: August 30, 2018
Coping with critical drug shortages: an ethical approach for allocating scarce resources in hospitals
Philip M Rosoff1, Kuldip R Patel, Ann Scates
1Department of Pediatrics, Duke University Medical Center, Durham, NC 27710, USA. philip.rosoff@duke.edu
Abstract:
The number of critical medication shortages in the United States has reached an unprecedented level, requiring decisions about allocating limited drug supplies. Ad hoc decisions are susceptible to arbitrary judgments, revealing preformed biases for or against groups of people. Health care institutions lack standardized protocols for rationing scarce drugs. We describe the principles on which an ethically justifiable policy of medication allocation during critical shortages was created at our hospital. Based on supportable scientific evidence and with all clinically similar patients treated as similarly deserving of consideration, drugs were distributed according to a hierarchy of clinical need and predicted efficacy. We explain the ethical rationale for the procedures we adopted, how the policy was implemented at a large academic medical center, and more than 1 year of experience with a number of different medications. Our experience has demonstrated the feasibility and utility of formulating a rational and ethically sound policy for scarce resource allocation in an academic teaching hospital that could be used in a variety of health care settings. The method has proven to be reliable, workable, and acceptable to clinicians, staff, and patients.
Related Concept Videos
Ethical Issues
Ethical Concerns in Healthcare:
Ethical Dilemmas II
Pharmaceutical Poisoning: Potential Scenarios
Nursing Ethical Principles II
Consider the following scenario, which illustrates how these principles are applied in the care of Mr. John, a fifty-year-old teacher diagnosed with metastatic liver cancer.
Initially, Mr. John's cancer...
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Pharmacokinetic–Pharmacodynamic Relationship: Problems

